Glycan foldamers: designing oligosaccharides to build three-dimensional architectures
The project aims to develop synthetic carbohydrate foldamers that adopt defined structures and assemble into complex architectures, enhancing understanding and applications in chemistry and material science.
Projectdetails
Introduction
Natural biopolymers have inspired the development of synthetic analogues, i.e., foldamers, capable of adopting defined conformations and forming programmable three-dimensional architectures. These compounds are mainly based on peptides and nucleic acids, which are well understood at the molecular level.
Potential of Carbohydrates
The diversity, intrinsic chirality, and ability to generate hierarchical assemblies suggest that carbohydrates hold an even larger potential for the generation of three-dimensional structures. However, the complexity of carbohydrate synthesis and structural analysis has prevented access to synthetic carbohydrates capable of adopting defined geometries.
Project Proposal
I propose the creation of carbohydrate foldamers capable of:
- Adopting rigid secondary structures
- Assembling into supramolecular architectures
To achieve these goals, we will address fundamental questions related to carbohydrate structure, design new methods to stabilize particular conformations, and implement protocols for systematic structural analysis.
Methodology
State-of-the-art synthetic platforms (i.e., automated glycan assembly) and analytical techniques (i.e., NMR spectroscopy, microED, and single molecule imaging) will be the tools to complete this ambitious project. My group has proved to be very successful at gaining a basic understanding of carbohydrate structure and aggregation.
Future Directions
Building upon these preliminary results, I aim to develop programmable carbohydrate architectures, which have the potential to open a new field of carbohydrate and supramolecular chemistry.
Applications
Analogous to the birth of a new field after the discovery of peptide-based foldamers, carbohydrate foldamers could find applications in several areas, including:
- Material science
- Biology
- Catalysis
Moreover, carbohydrate foldamers will expand our understanding of carbohydrate structures and interactions, and new analytical protocols will standardize the characterization of carbohydrate materials.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.956 |
Totale projectbegroting | € 1.499.956 |
Tijdlijn
Startdatum | 1-1-2023 |
Einddatum | 31-12-2027 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EVpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
GlycoRoads: A platform for the de novo design of glycansGlycoRoads aims to develop an AI-driven platform for de novo glycan design using molecular dynamics simulations to create a comprehensive database, enhancing customization for therapeutic and material applications. | ERC Proof of... | € 150.000 | 2025 | Details |
BiFoldome: Homo- and Hetero-typic Interactions in Assembled FoldomesBiFOLDOME aims to understand co-assembly in amyloids through innovative NMR techniques, enhancing insights into self-assembly and potential applications in disease-related protein manipulation. | ERC Starting... | € 1.496.823 | 2022 | Details |
Entangled tertiary foldsProteoKnot aims to design entangled tertiary folds in synthetic molecules for dynamic functionality, enabling complex macromolecules with protein-like properties and switchable catalytic capabilities. | ERC Consolid... | € 1.999.454 | 2023 | Details |
Glycan Mimetics for Cell Glycocalyx Reconstitution: a polymer chemist’s approach to fight infectionGLYMCE aims to uncover how carbohydrates influence pathogen interactions to create innovative glycopolymer materials for infection prevention and treatment. | ERC Consolid... | € 1.994.024 | 2024 | Details |
Design of Nucleic Acid-Templated Ordered Protein AssembliesThis project aims to develop nucleic acid-templated protein assemblies using innovative approaches to control their size, shape, and functionality for potential applications in living cells. | ERC Starting... | € 1.499.711 | 2024 | Details |
GlycoRoads: A platform for the de novo design of glycans
GlycoRoads aims to develop an AI-driven platform for de novo glycan design using molecular dynamics simulations to create a comprehensive database, enhancing customization for therapeutic and material applications.
BiFoldome: Homo- and Hetero-typic Interactions in Assembled Foldomes
BiFOLDOME aims to understand co-assembly in amyloids through innovative NMR techniques, enhancing insights into self-assembly and potential applications in disease-related protein manipulation.
Entangled tertiary folds
ProteoKnot aims to design entangled tertiary folds in synthetic molecules for dynamic functionality, enabling complex macromolecules with protein-like properties and switchable catalytic capabilities.
Glycan Mimetics for Cell Glycocalyx Reconstitution: a polymer chemist’s approach to fight infection
GLYMCE aims to uncover how carbohydrates influence pathogen interactions to create innovative glycopolymer materials for infection prevention and treatment.
Design of Nucleic Acid-Templated Ordered Protein Assemblies
This project aims to develop nucleic acid-templated protein assemblies using innovative approaches to control their size, shape, and functionality for potential applications in living cells.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Inhibitor-Mediated Programming of GlycoformsThe project aims to revolutionize glycan manipulation using Inhibitor-Mediated Programming of Glycoforms (IMProGlyco) to create precision-engineered therapeutic proteins and enhance cellular functions. | EIC Pathfinder | € 2.998.878 | 2025 | Details |
Inhibitor-Mediated Programming of Glycoforms
The project aims to revolutionize glycan manipulation using Inhibitor-Mediated Programming of Glycoforms (IMProGlyco) to create precision-engineered therapeutic proteins and enhance cellular functions.